Distribution deal between Dr.Vet and Centauro.

Distribution deal between Dr.Vet and Centauro.

Distribution deal between Dr.Vet and Centauro.

Böthmen Pharma and the distributor Centauro have signed an agreement to market Dr.Vet's family of natural nutraceutical products in Spain.

The Dr.Vet products, which were presented with great acceptance at the AVEPA SEVC Veterinary Congress last November, are designed based on a rigorous R&D process, and are indicated to alleviate and prevent related pathologies. to animal health, especially of dogs and cats.

The brand, born in Barcelona, ​​has several lines, among which the innovative ophthalmology line stands out, indicated for glaucoma, cataracts, retina and dry eye, and which has had the collaboration and supervision of the Veterinary Ophthalmological Institute of Barcelona- IVO.

It also has osteo-articular, psycho-revitalizing, dietary, liver and kidney products in its catalog,

Centauro, has more than 25 years of activity in Spain, and its activity is focused around the pet animals sector, providing a very different added value within the sector.

Centauro has a market penetration share of 40% in the area where it operates. In addition to Catalonia as the main area of ​​influence, the company is also present in the rest of the national territory.

The agreement for the distribution of Dr.Vet brand products in Spain was signed at the Centauro facilities and was attended by Gemma Vivet and Francesc Giné de Centauro and Ignasi Solana and Miguel Cuadrado from the Böthmen Pharma laboratories, manufacturer of Dr.Vet brand products.

During this year, the launch and presentation to veterinary professionals of the brand's new products is planned, coinciding with the celebration of the SEOVEP Veterinary Ophthalmology Congress, as well as the International Fair Iberzoo + Propet and VetMadrid.

Andersen invests in Böthmen Pharma Laboratories

Andersen, SA, a company founded in 1974, which is dedicated to manufacturing and distributing products for animal health and nutrition, has acquired 51% of Böthmen Pharma laboratories’ shares.

Böthmen Pharma, company, located in Barcelona and founded by Miguel Cuadrado and Ignasi Solana, has designed, under the brand name Dr.Vet, a wide variety of dietary supplements designed to palliate and prevent pathologies that impact the health and quality of life of cats and dogs. Notably, the creation and development of its innovative ophthalmological veterinary product line.

With this operation, framed within an ambitious growth and expansion plan in the veterinary market, Andersen steps into the Pet Care sector.

We use cookies to ensure that we give the best user experience on our website. You can read our privacy and cookies policy here.